Abstract
Kawasaki disease is an acute vasculitis that is characterized by prolonged fever, nonpurulent conjunctivitis, oral mucosal inflamation, cervical lympadenophaty, erythema of the hands and feet, and diffuse polymorphous skin rash. The most common age of occurence is between 6 months and 5 years. Coronary artery aneurysms may develop in % 15-25 of untreated children and may lead to sudden death or myocard infarction. So early diagnosis and treatment with intravenous immunoglobulin and acetyl salicylic acid are important to prevent this complications. Here, we present a atypical Kawasaki disease, five year old case was treated on time and had no complication.
References
- Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004;364:533-544.
- Ö.M.Bostan. Kawasaki Hastalığı. J Pediatr Inf 2011;5:46-50.
- Cimaz R,Sundel R. Atypical and incomplente Kawasaki disease. Best Pract Res Clin Rheumatol 2009;23:689-97.
- Lin KH, Chang SS, Yu CW, Lin SC, Liu SC, Chao H, et al. Usefulness of natriuretic peptide for diagnosis of Kawasaki disease: a systematic review and meta-analysis. BMJ Open 2015;5.
- Newburger JW, Takahashi M, Gerber MA et all. Diagnosisi,treatment,and long-term management of kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease,Council on Cardiovascular Disease in the Young American Heart Association. Pediatrics 2004;114:1708-33.
- Kobayashi T, Kobayashi T, Arakawa H. Prednisolone therapy for Kawasaki disease. Nihon Rinsho 2014;72:1623-8.
- Koren G,Lavi S,Rose V,Rowe R. Kawasaki disease:review of risk factors for coronary aneurysms.J Pediatr 1986;108:388-92.
Abstract
Kawasaki hastalığı uzun süren ateş, pürülan olmayan konjunktivit, ağız mukozasında inflamasyon, servikal lenfadenopati, el ve ayaklarda eritem, yaygın polimorf deri döküntüsü ile karakterize bir vaskülittir. En sık 6 ay-5 yaş arasında görülür. Kawasaki hastalığının % 7-10’u atipik seyirli olmaktadır.Tedavi edilmeyen olgularda %15-25 oranında koroner arter anevrizmaları, miyokard infarktüsü ve ani ölüm gibi kardiyak komplikasyonlar gelişebilir. Bu nedenle hastalığın erken teşhis edilmesi, intravenöz immünglobülin(IVIG) ve asetilsalisilik asit(ASA) ile tedaviye başlanması bu tür komplikasyonların gelişimini önlemek açısından önemlidir. Burada atipik Kawasaki hastalığı tanısı alan ve tedaviye cevap veren olgu sunulmuştur.
References
- Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004;364:533-544.
- Ö.M.Bostan. Kawasaki Hastalığı. J Pediatr Inf 2011;5:46-50.
- Cimaz R,Sundel R. Atypical and incomplente Kawasaki disease. Best Pract Res Clin Rheumatol 2009;23:689-97.
- Lin KH, Chang SS, Yu CW, Lin SC, Liu SC, Chao H, et al. Usefulness of natriuretic peptide for diagnosis of Kawasaki disease: a systematic review and meta-analysis. BMJ Open 2015;5.
- Newburger JW, Takahashi M, Gerber MA et all. Diagnosisi,treatment,and long-term management of kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease,Council on Cardiovascular Disease in the Young American Heart Association. Pediatrics 2004;114:1708-33.
- Kobayashi T, Kobayashi T, Arakawa H. Prednisolone therapy for Kawasaki disease. Nihon Rinsho 2014;72:1623-8.
- Koren G,Lavi S,Rose V,Rowe R. Kawasaki disease:review of risk factors for coronary aneurysms.J Pediatr 1986;108:388-92.
Details
| Primary Language | Turkish |
|---|---|
| Journal Section | Case Report |
| Authors | |
| Publication Date | March 1, 2017 |
| Published in Issue | Year 2017 Volume: 48 Issue: 1 |
